SLC17A6 and Parkinson disease: Utilizing vGluT1, a marker for corticostriatal terminals and vGlut2, a marker for thalamostriatal terminals [74–77], it was previously reported that the corticostriatal terminals are increased in the putamen of PD brains [71].